BLU Insider Trading

Insider Ownership Percentage: 9.61%
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$881,536.08

BELLUS Health Insider Trading History Chart

This chart shows the insider buying and selling history at BELLUS Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BELLUS Health Share Price & Price History

Current Price: C$10.70
Price Change: Price Increase of +0.06 (0.56%)
As of 03/22/2023 01:00 AM ET

This chart shows the closing price history over time for BLU up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BELLUS Health Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/30/2022Pierre LarochelleDirectorSell35,667C$12.59C$448,976.20131,389
11/18/2022Joseph RusDirectorSell35,643C$12.14C$432,559.88
3/22/2022Francois DesjardinsSenior OfficerSell14,053C$8.47C$118,989.5681,722
10/20/2020Roberto BelliniDirectorBuy42,500C$3.05C$129,591.00630,062
7/13/2020Pierre LarochelleDirectorBuy55,000C$3.75C$206,250.00131,389
7/6/2020Francesco BelliniDirectorBuy50,000C$3.82C$191,058.00397,479
6/10/2020Orbimed Advisors LLC InsiderSell36,400C$14.08C$512,657.601,182,416
See Full Table

SEC Filings (Institutional Ownership Changes) for BELLUS Health (TSE:BLU)

89.17% of BELLUS Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

BELLUS Health logo
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.
Read More on BELLUS Health

Today's Range

Now: C$10.70
Low: C$10.43
High: C$11.24

50 Day Range

MA: C$10.54
Low: C$10.07
High: C$11.11

52 Week Range

Now: C$10.70
Low: C$7.41
High: C$16.24


61,120 shs

Average Volume

51,568 shs

Market Capitalization

C$1.35 billion

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of BELLUS Health?

BELLUS Health's top insider shareholders include:
  1. Pierre Larochelle (Director)
  2. Francois Desjardins (Senior Officer)
  3. Joseph Rus (Director)
Learn More about top insider investors at BELLUS Health.